Clinical Trial Update: Durvalumab Combined With Chemoradiotherapy for Limited Stage Small Cell Lung Cancer (Camel-01) [Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 2 study of durvalumab combined with chemoradiotherapy for limited-stage small cell lung cancer; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: SCLC, Limited Stage | Phase 2 | Status: RECRUITING